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Abstract In some diseases, a very important role is played by
the ability of bacteria to form multi-dimensional complex
structure known as biofilm. The most common disease of the
oral cavity, known as dental caries, is a top leader. Streptococcus
mutans , one of the many etiological factors of dental caries, is a
microorganismwhich is able to acquire new properties allowing
for the expression of pathogenicity determinants determining its
virulence in specific environmental conditions. Through the
mechanism of adhesion to a solid surface, S. mutans is capable
of colonizing the oral cavity and also of forming bacterial
biofilm. Additional properties enabling S. mutans to colonize
the oral cavity include the ability to survive in an acidic
environment and specific interaction with other microorganisms
colonizing this ecosystem. This review is an attempt to establish
which characteristics associated with biofilm formation—
virulence determinants of S. mutans—are responsible for the
development of dental caries. In order to extend the knowledge
of the nature of Streptococcus infections, an attempt to face the
following problems will be made: Biofilm formation as a
complex process of protein–bacterium interaction. To what
extent do microorganisms of the cariogenic flora exemplified
by S. mutans differ in virulence determinants “expression”
from microorganisms of physiological flora? How does the
environment of the oral cavity and its microorganisms
affect the biofilm formation of dominant species? How do
selected inhibitors affect the biofilm formation of cariogenic
microorganisms?
Introduction
In the 18th century, it was demonstrated that microorganisms
live not only in a single-cell form, but are also capable of
forming clusters suspended in a mucilaginous extracellular
substance. The pathogenicity of certain microbial species such
as Streptococcus mutans , Staphylococcus epidermidis ,
Legionella pneumophila or Pseudomonas aeruginosa is
inseparably associated with their ability to form biofilms on
solid surfaces, e.g., tissues, catheters or implants [1–4]. This
feature allows microorganisms to form three-dimensional
structures in which cells become more resistant to antibiotics
and changing environmental conditions, among others,
through changes occurring as a result of interbacterial
interactions and the presence of an exopolysaccharide matrix
protecting the entire structure [5, 6].
Microorganism pathogenicity
Interactions observed between pathogen and host have
been the subject of research and discussion for many years.
The historical approach to the problem of microorganism
pathogenicity postulated by, amongst others, Koch, puts the
pathogen or host in themain position by this featured affiliation
to one of them. The term ‘pathogenicity determinants’ is
related to the features which determine a microorganism’s
ability to cause disease, but which themselves are not required
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for its survival [7]. Henderson et al. defined pathogenicity
determinants as pathogen components which cause damage
in a host organism; this may include factors vitally important
for the microorganisms [8]. These definitions do not, however,
take into account the role of host susceptibility to infection,
indicating only that pathogen properties are responsible for
disease development. According to these definitions, only
those microorganisms which cause diseases in healthy
people are pathogens and not opportunistic or commensal
microorganisms which are only able to infect the hosts with
immune system disorders.
Casadevall and Pirofski [9] proposed a new definition
for pathogenicity and pathogenicity determinants of the
microorganisms taking into account the state of host
immunological defense. A given microorganism pathogenicity
is expressed as a range of damage which is caused by the
microorganism itself and by the immune system as a response
to a pathogen. The state of a host’s immunological defense is
the main determinant for bacterial pathogens and it determines
the infection course and cure [9].
The determination of microorganism pathogenicity
determinants according to the classification proposed by
Casadevall and Pirofski (six classes) poses some interpretation
problems in class I, since it seems that the key role in these
infections is played by a host’s condition. The infected human
constitutes a complex ecosystem in which homeostasis in
the field of the bacteria-immune system is observed in the
physiological state. The development of bacteremia
occurs in cases of disturbances in this system, usually as
a result of immunity deficiency or, more rarely, as a result
of an overexpression of the features determining bacteria
pathogenicity. There are, however, some bacteria, e.g., S.
salivarius or most bacteria colonizing the oral cavity,
which live in the human environment but are rarely described
as pathogens, even in those patients with an impaired immune
system. This suggests that even pathogens of a low virulence
have to possess a minimum set of features determining their
pathogenicity, which would allow them to penetrate and
proliferate in a host organism.
In the study by Kreikemeyer et al. [10] concerning biofilm
structure, the determinants of Streptococcus pathogenicity are
related to the discovery of long filamentous structures similar
to the pilus observed on bacteria surfaces. These structures
exhibit adhesive properties and may play a key role in
adhering to host cells and tissues, as well as in biofilm
formation by pathogens of the Streptococcus species. The
study demonstrated that the described pilus in S. pyogenes
are responsible for bacteria adhesion and the formation of
microcolonies on host cell surfaces, and also for aggregation
itself, especially when influenced by human saliva. Also, in
the case of S. agalactiae , these structures are engaged in
pathogen interaction with host cells, e.g., adherence and
bypassing the epithelium barrier. They are also responsible
for bacteria clustering in a biofilm-like structure. In the
pathogenesis of the diseases caused by S. pneumoniae , as in
the case of other Streptococcus species, these structures are
engaged in adhesion and colonization processes; however,
compared to other Streptococcus species, the frequency of
pilus occurrence is lower (less than 30 %) [11].
There are studies suggesting that S. mutans isolates have a
greater ability to form biofilm than the isolates of other
Streptococcus species, which colonize the human oral cavity
environment [12, 13]. The studies focused on S. mutans cells,
which form biofilm and proved that they exhibit a different
expression of some proteins in comparison to planktonic
cultures, e.g., an increase in exopolyphosphatase expression
and a decrease of lactate dehydrogenase or pyruvate kinase
expression [14]. Increased virulence of cells forming biofilm
can also be associated with a higher tolerance to low pH, as
compared to planktonic cultures.
The main components of the biofilm formed on the surface
of teeth include: glucan (10–20 % of dry weight), fructan
(1–2 % of dry weight) and proteins (40 % dry matter).
Moreover, it differs from the surrounding saliva in terms
of the levels of lipids, calcium, magnesium, fluorine, and
phosphorus. In situ, in 80 % it consists of water [6]. Thus,
an amorphous membrane formed in such conditions provides
ideal conditions for bacterial survival and determines the
virulence of the biofilm structure. Physical and biochemical
matrix features allow for the adhesion of microorganisms,
promote cohesion (the aggregation of cells), and act as a source
of energy reservoirs. Moreover, limited diffusion to and from
the biofilm helps to focus the ions and other nutrients in the
microenvironment, such as biofilm; however, it hinders the
penetration of substances from outside, including antibiotics
[6]. It can be observed that bacteria in the biofilm resemble
other organisms for which the clustering was also an
evolutionary adaptation for survival.
The ability of bacteria of the S. mutans species to form
biofilms is significant from a clinical point of view, mainly in
the context of carries etiology; however, there are also single
casuistic cases of infective endocarditis (IE) with the
involvement of this bacteria [15, 16]. The development of IE
is observed when endocardial damage occurs followed by the
formation of a very small blood clot, in which platelets play a
crucial role. If, at the same time, microorganisms enter the
bloodstream, they may use these favorable growth conditions
for deposition and biofilm formation.
Such microclots are formed at the interface of the mitral
and tricuspid valves from the side of atria and from the side of
chambers at the aortic and pulmonary valves [17]. The
survival of S. mutans in the bloodstream, where it is very
rarely observed after dental surgery, is associated with the
presence of several virulence factors on the surface of bacteria,
and these have been described in different cases of IE caused
by this microorganism. First are those factors responsible for
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the increased resistance of proteins to phagocytosis, namely,
the fibronectin-binding protein (so-called autolysin A, AtlA)
[18] and serotype-specific polysaccharide [19]. Next, C antigens
increased platelet aggregation, initiating the coagulation cascade
process and, consequently, often leading to hypercoagulable
states [20]. An equally important role is attributed to the
collagen-binding protein (Cnm) [21], so that the S. mutans
bacterium can adhere to the heart tissue and penetrate the
endothelium of the coronary arteries, consequently leading
to endocarditis [22].
Biofilm formation as a complex process
of protein–bacterium interaction
The most common oral cavity infectious disease in which an
important causative role is played by biofilms formed by
microorganisms on the teeth and gums surface is dental caries.
One of the main etiological factors of the above-mentioned
disease is S. mutans [23–25].
Caries is the most common childhood illness. It is estimated
to occur five times more often than the second most common
childhood illness, asthma [26]. The Decayed, Missing and
Filled Teeth (DMFT) index rate was observed for Bolivia,
Guatemala, Bosnia andHerzegovina, and Philippines. Directly
behind them in contrast, the lowest DMFT index rate was
observed for Russia, Europe’s Eastern Bloc including Poland,
and most South American countries [27, 28].
Comparing the DMFT index rate for European countries,
one can observe that the epidemiological situation in Poland is
not ideal. In 2012, the DMFT index rate for 12-year-olds was
estimated at 4.4, whereas the lowest observed in Holland was
estimated at 0.9 and the highest in Latvia was estimated at 7.7.
In terms of 6-year-olds, the situation deteriorates because,
among the countries under investigation, the highest DMFT
index rate equal to 5.1 was recorded in Poland. It is estimated
that, in Poland, dental caries is observed in 35–50 % of
children aged 2–3 years and in 50–60 % of children aged 3–
4 years [27, 29]. According to alarming reports from the
World Health Organization (WHO) and the National Institute
of Public Health (PZH), dental caries is observed in almost
100 % of children aged 6–7 years. Caries in permanent teeth
starts just after the dentition of the first molar teeth and has
been reported in approximately 90 % of Polish 12-year-old
children [30, 31].
In the view of the above data, it is extremely important to
understand more fully the mechanisms of cariogenic strain
activity on the basis of the biofilm formed by them, which
may be applied in the prevention and early diagnostics of
dental caries in children.
Biofilms present in the oral cavity are three-dimensional
structures, consisting of bacterial strains anchored to solid
surfaces such as tooth enamel, tooth roots or dental implants.
They are embedded in an exopolysaccharidematrix [32]. Over
700 different bacterial species incorporating into biofilms have
been identified so far [33, 34]. The structure and composition of
the exopolysaccharide matrix is determined by the conditions
existing in the oral cavity and change over time. The
extracellular polysaccharides (EPS) also affect the physical
and biochemical properties of the biofilm [6, 35].
The primary sources of EPS are glucosyltransferase (GTF)
and fructosyltransferase (Ftf), products of interaction with
sucrose and starch hydrolysates. Exopolymers contained in
the polysaccharide matrix form its stability and provide
possibilities of binding bacterial cells [6, 35, 36]. Research
on the composition of the polysaccharide matrix revealed the
presence of components as shown in Fig. 1.
The process of biofilm formation begins with the coating of
the tooth surface through the salivary pellicle [6, 32]. This
pellicle is formed by salivary components (such as proline-
rich proteins, amylase, lysozyme, histatin, peroxidase, mucin,
and bacterial components, e.g., Ftf, Gtf, lipoteichoic acid)
specifically adsorbed to the acquired enamel pellicle (AEP)
[6, 37]. AEP is the basis for microorganism-induced biofilm
formation colonizing the oral cavity [37]. Single S. mutans
cells or their aggregates fuse with pellicles via two independent
mechanisms: sucrose-dependent and sucrose-independent [23,
25, 32].
The sucrose-dependent mechanism
Glucosyltransferases (GtfS)
The sucrose-dependent mechanism of plaque formation is
based on glucosyltransferases (GTFB, -C, and-D) produced
by S. mutans in combination with glucan-binding proteins
(GBPs) [6, 25, 38]. Glucosyltransferases play critical roles in
Fig. 1 The percentage composition of polysaccharide matrix (the figure
was prepared based on the data published by Bowen and Koo [6])
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virulent dental plaque development and are responsible
for glucans formation from sucrose. The synthesized
glucans provide the possibility of both bacterial adhesion
to the tooth enamel and microorganisms to each other. Thanks
to this process, microcolonies are formed which favor the
formation of biofilm. Each of the three types of Gtf plays a
different, though similar role in biofilm formation and,
therefore, the loss or mutation of one of them impairs the
whole process [6, 38].
In vivo, GtfS very rapidly (approximately 1 min) adsorbs
into the hydroxyapatite surface (sHA) of the enamel-coated
salivary pellicle. The highest affinity for the sHA is reported
for GTFC (formally known as GtfSI), which is a hydrophilic
compound and produces a mixture of soluble (with mostly α-
1,6-linkages) and insoluble glucans. However, it has a
hydrophobic domain which is related to its affinity for dental
plaque. This enables the interaction with saliva proteins in the
pellicle, such as lysozyme or α-amylase. GtfB (known as
GtfI), a glucosyltransferase, is primarily responsible for the
interaction with other S. mutans bacteria which mainly
synthesize insoluble glucan rich in α-1,3-linkages. It is
responsible for the formation of highly differentiated
microcolonies forming the structure of biofilm [39]. Its
activity significantly increases when there is a glucose in the
environment, which is not a typical situation and is observed
extremely rarely [6, 40].
GtfD (GtfS) predominantly forms soluble, quickly
metabolizable polysaccharides and acts as a primer for GtfB.
Glucosyltransferases also interact with the components of
saliva: amylase, in consequence blocking the activity and
adsorption to hydroxyapatite; lysozyme, which decreases the
activity of GtfB, but does not affect the characteristics of
glucans formed by the enzyme; peroxidase, which inhibits
the activity of all three glycosyltransferases.
GtfS also have the ability to bind to other bacterial
cells, even if these are not bacteria synthesizing their own
glycosyltransferases. Therefore, cooperation between Gtfs
and microorganisms allows for the building of a plate strongly
attached to the teeth surface with stable bonds between
bacterial cells [6, 35].
Genes encodingGtfB and GtfC lie close to each other, have
a very similar amino acid composition (95 % homology), and
are subject to the same regulatory processes. These genes are
expressed in response to acidification of the environment or in
situations of glucose or sucrose excess in the environment.
Many factors additionally influence the physiological
expression of these genes. One of them is catabolism and
factors like RegM, an inhibitory regulator of S. mutans [6].
The protein regulating the catabolism in Streptococcus and
Staphylococcus bacteria, RegM, is also known as catabolite
control protein A (CCPA) [41]. Its regulatory function is based
on the inhibition of genes involved in the utilization of
alternative carbon sources and the activation of the expression
of genes whose products are involved in the elimination of
excess carbon from the cell [42–44]. Inactivation of the RegM
of S. mutans results in a very strong decrease in the promoter
expression of gtfBC [6]. Other factors are the products of
genes: luxS (AI-2 autoinducer-coding synthesis), which
affects the expression of gtfB and gtfC [6, 25, 45], and also
ropA (encoding for the trigger factor) regulating the
production of GtfB and GtfD [6, 23]. Also, the VicRK signal
transduction system affects the physiological expression of
Gtfs. In a mutant strain of S. mutans which does not have this
system, a significant decrease in gtfD gene expression, as well
as increased expression of the gtfB gene, was observed.
The gtfD gene lies distant from other genes, is characterized
by lesser homology (50 %) and is subject to different regulatory
mechanisms. Its expression is specifically induced by copper
ions [6]. Apart from Gtfs, the synthesis and structure of glucans
is also affected by enzymes such as mutanase and α-1,6-
glucosidase. Therefore, the structure of glucans in the biofilm
matrix is changeable, and in mature dental plaque, water-
insoluble polysaccharides dominate [6, 46, 47].
Glucans binding of proteins (Gbps)
Another component of the sucrose-dependent mechanism is
Gbps mediating the binding of bacteria to glucans. Four types
of this protein are known: GbpA, -B, -C, and -D [6, 25, 38].
The GBPC protein (and probablyGbpB) is associatedwith the
bacterial cell wall and, therefore, acts as a specific receptor for
glucan. All four types of proteins play a role in microorganism
adhesion and biofilm formation; however, the GbpD protein
seems to play a key role [6]. Research on the utility of GS5
(deletion of the gbpB gene) and UACA2 (a strain of the gbpB
gene expression encoding antisense RNA) of S. mutans
strains showed that the absence or mutation of the gene
encoding GbpB results in a change of cell shape and a slowing
down of its growth [38]. This disables the appropriate
development of biofilm, which, instead of a diverse, dense
formation, becomes a product of non-regular cell clusters
surrounded by a matrix of unusual structure.
The expression patterns of GbpB which have been studied
by Fujita et al. [40] may have some relationships with S.
mutans virulence. Attention was paid to the relationship of
the profiles and biological activity of the above-mentioned
proteins with the virulence of isolated proteins. GbpB
expression analysis isolates revealed the existence of several
expression patterns. Strains that showed single and multiple
bonding were classified as S and M strains, while strains
without explicit GbpB expression were classified as N
type. The GbpB expression pattern distribution was found
to be different for the Japanese and Finnish clinical strains
simultaneously.
For the Japanese strains, the highest frequency was
reported for S (81 %), followed by the M (15 %) and N types
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(4 %), while in the Finnish population, the frequencies were
estimated at 42 % for the M type, 37 % for the S type, and
21 % for the N type without the explicit expression of GbpB.
Studies show a clear differentiation of each type depending on
the origin of clinical isolates. Geographic variation seems to
be crucial in determining the virulence of the strains, which,
depending on the environment, do or do not acquire specific
virulence factors, constituting a kind of adaptation which
allows them to colonize a new ecological niche. An
explanation of the distribution and specificity of GbpB
expression patterns may be useful for the evaluation of S.
mutans virulence in individual patients [40].
The sucrose-independent mechanism
The sucrose-independent mechanism is not relevant in the
virulence of S. mutans . In the second mechanism of adhesion
(sucrose-independent), an interaction is observed between the
adhesive particles of S. mutans and the AEP. Agglutinins
found in saliva are involved in the process of adhesion and
aggregation of S. mutans thanks to interaction with the I/II
antigen, which is a multifunctional PI adhesin (also known as
AgB, SpaP, or Pac1 adhesin) anchored in the bacterial cell
wall, and encoded by the spaP gene [23–25, 48].
The protein family of Ag I/II, represented by SpaP, SspA,
or SspB, is identified not only on the surface of S. mutans , but
also on other microorganisms, such as Streptococcus
pyogenes , Streptococcus agalactiae , or Streptococcus suis
[48]. Genetic sequences encoding Ag I/II comprise six distinct
regions. The most important of these are the A region rich in
alanine and the P region rich in proline. Region V, located
between them, is composed in the majority of different
sequences found in individual strains. The A and V regions
encode adhesive epitopes appearing on the surface of bacterial
cells (so-called adhesive types) responsible for affinity to the
salivary glycoproteins [49]. The contribution of the A, P, and
V regions to the adhesion has been confirmed by studies using
mutant strains [48]. None of them had the ability to adhere to
solid surfaces coated with the salivary pellicle. The expression
and biological activity of the P1 protein in S. mutans is also
dependent on multiple gene products, i.e., luxS, ropA, and
srtA genes (encoding the enzyme responsible for the
attachment of P1 adhesin to the cell wall) [22, 50].
The SpaP protein and other proteins of the Ag I/II family
specifically interact with glycoprotein-340 (gp-340) found in
saliva. It is interesting that the gp-340 dissolved in the liquid
phase of saliva plays a role in the aggregation of bacterial cells
and, thus, purifies the oral cavity. However, if gp-340 is
adsorbed on the surface of the teeth or gums, it acts as a
receptor for surface bacterial adhesins initiating the adhesion
process [22, 48] (Fig. 2). The Ag I/II protein family is also
involved in the interaction between microorganisms, e.g.,
Streptococcus gordonii and Porphyromonas gingivalis , and
in the aggregation of cells in the absence of gp-340 [48].
A key role in the interactions between S. mutans and saliva
agglutinins is played by the actual structure and location of P1
protein, as has been proven through the use of mutant strains
(spaP and srtA) of this microorganism. Additionally, it has
been shown that the lack of expression of the gene encoding
sortase A enzyme (SrtA) results not only in an abnormal
location of the P1 adhesin, but also of other surface proteins,
which is not negligible in the context of bacterial aggregation
ability [23]. The survival of S. mutans inside biofilms, at a
very low pH inside microcolonies of other bacterial species
(as observed in the oral cavity), should be considered as three
mechanism-dependent phenomena which include: the
upregulation system of F1F0-ATPase, biosynthesis of
membrane fatty acids (for instance, FabM), and branched-
chain amino acid (BCAA) (for instance, IIvC). This process
may be the main driving force in the survival of S. mutans
inside a mixed biofilm (Fig. 3); thus, innovative therapies
aimed at inhibiting biofilm formation should be oriented along
these three mechanisms and should be directed at all three
simultaneously and not just in one of them [51].
Salivary agglutinins
In the process of biofilm formation, a role equally important as
that of surface bacterial adhesins is played by salivary
agglutinins. This has been confirmed in vitro [23, 24].
Researchers have also used mutant bacterial strains of the
major genes encoding the P1 protein to study the differences
and interactions during biofilm formation. The results clearly
indicate a less satisfactory process in the absence of salivary
agglutinins, as well as significantly less sufficiency in the
mutant strains compared to the parental strain [22, 23].
It has also been proven that the initial stage of adhesion
and biofilm formation of S. mutans may be stimulated
by salivary agglutinins and other salivary proteins (e.g.,
mucin of high molecular mass or acidic proline-rich proteins)
(Fig. 2) [23, 52].
Under specific conditions, the expression of the virulence
factors of S. mutans and biofilm formation in the oral cavity
may be modulated in two ways: through the environment in
which bacterial growth was reported as well as by the
presence of other microorganisms, and the interactions
between them [25].
Culturing S. mutans strains under aerobic conditions
induces an 80% reduction of bacterial ability to form biofilms
[23]. Oxygen availability is the causative agent of variations in
bacterial cell surface composition and modification of the
production of autolysins and, specifically, in the signal
transduction system of VicRK (Fig. 2). The production of AtlA
autolysin is conditioned by the SMu0629 gene expression of
oxidoreductase activity. Under aerobic conditions, increased
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expression of this gene is being observed and, thus, the
overproduction of AtlA autolysin, which inhibits the formation
of biofilm. Vick kinase transducer is a system regulating the
expression and activity of AtlA autolysin. In order to confirm
oxygen-induced alterations in autolysin, studies on mutant
strains for SMu0629 and vicK genes were conducted. Strains
from which the above-mentioned genes were removed adapted
better to aerobic conditions and showed a greater ability to form
biofilm as compared to the UA159 parental strain [52–54].
Diet habits
Diet is another factor influencing the process of biofilm
formation. The occurrence of dental caries is strongly
correlated to diet. Meal cariogenicity is affected not only by
the content of carbohydrates but also by the frequency of their
consumption. Particular carbohydrates differ in their ability to
cause caries. Saccharose is definitely the most cariogenic
carbohydrate [55]. It constitutes the main center of S. mutans
metabolism. These bacteria exhibit not only the ability to
decompose this carbohydrate, but also produce glucans which
are significant in interactions between tooth enamel and
cariogenic bacteria [6].
The presence of high levels of carbohydrates in children’s
diets, especially in the drinks given to children immediately
before sleep or during the night, constitutes a significant factor
in ECC development [56]. Falling asleep with a sweetened
nipple or bottle in the mouth stimulates the formation of
carious lesions. Saliva excretion decreases during sleep, which
accelerates the cariogenic strength of the activity of acids
Fig. 2 The function of Streptococcus mutans in the process of the
formation of biofilms on the surface of teeth. Glycosyltransferases
(GTF) are an indispensable element for the proper functioning of S.
mutans . In the early phase of biofilm development, S. mutans are bound
to the teeth surface. It is thought that this binding is the first step in the
formation of plaque. Surface adhesins of S. mutans (so-called antigen I/II)
interact with α-galactosides from saliva, forming the structure of
pellicula. Other groups of compounds belonging to S. mutans and located
on the surface of teeth which participate in the formation of pellicula are
glucan-binding proteins (GBPs) or GTF. Salivary proteins with which can
interact the surface adhesins of S. mutans can be divided into four groups
depending on the time of pellicula formation. Proline-rich proteins (PRP)
participate in the first stage of the formation of pellicula. Two hours
later, enamel is formed by cystatins, peptides with high affinity to
hydroxyapatite. Then, peptides with low molecular weight and with
bacteriological properties against S. mutans start playing a role in this
model. In the last stage, mucin-rich proteins, lactoferrin, lysozyme,
amylase, albumin, or IgM and IgG antibodies are involved in the process.
S. mutans are aggregated on the surface of teeth in the presence of
saccharose. Additionally, GTF synthetizes extracellular glucans, which
is another key step in the development of plaque. GBP is a S. mutans
receptor that differs from GTF and specifically binds glucans. GTF
contain a glucan-binding domain and, therefore, they act as receptors
for glucans. Therefore, S. mutans binds initially developed glucan
through GBP and GTF, which gives a basis for the aggregation
of S. mutans
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derived from carbohydrate metabolism. The opinions
concerning the effect of feeding with milk on dental caries
development still remain controversial. According to
researchers, cow milk does not contain high amounts of
lactose and, moreover, no significant relationship with
carious lesion formation has been demonstrated. Human milk,
in turn, despite having higher amounts of lactose, also
contains case in which adsorbs to the tooth surface and retards
caries development. Moreover, it contains considerable
amounts of calcium and phosphates, which additionally
stimulate enamel remineralization [57]. Also, the significant
influence of sparkling drinks and fruit juice on dental
caries development in children and teenagers has been
demonstrated. Acids common in sparkling drinks, such as
citric or phosphoric acids, considerably lower the oral cavity
pH and stimulate an exchange of calcium ions present in the
enamel on hydrons. It has also been demonstrated that
drinking through a straw elongates and increases liquid
contact with the tooth surface, which unprofitably affects their
structure [58].
It is not the level of carbohydrates in ameal but the frequency
of consumption of meals with high carbohydrate levels that is a
significant factor [59]. Also, time plays a substantial role in tooth
mineralization. It has been demonstrated that alternate processes
of enamel demineralization and remineralization occur during
the day. The loss of hydroxyapatite mineral components is
related to the period when bacteria fermenting carbohydrates
may freely develop and synthesize acids into carbohydrates
metabolism byproducts. Time acts in favor of cariogenic
pathogens which adapt to low pH values, which favor the
progress of the cariogenic process. The length of change in the
period on the enamel surface is especially significant in cases of
early childhood caries characterized by an aggressive course.
Noticing the first changes on the upper incisor surface is
extremely important, since carious lesions quickly spread on
molar teeth [60]. Moreover, the changes in the daily rhythm of
saliva excretion play a significant role in caries exposure. Saliva
secretion is decreased during the night hours, which limits its
ability to protect against enamel demineralization [58].
Currently, studies on the development of products to
prevent dental caries development are being conducted. Some
are aimed at inhibiting the development of biofilm through the
influence on Gtfs. There are a number of synthetic and natural
glycosyltransferase inhibitors, i.e., hop components, green tea,
Fig. 3 Production of lactic acid
by Streptococcus mutans .
Metabolism of various
carbohydrates (including glucose
and fructose) by bacterial biofilm.
Production and secretion of a
significant amount of lactic acid,
which can cause demineralization
of teeth structure that can finally
result in the development of decay
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medicinal plant extracts, plant polyphenols of high molecular
mass (e.g., curcumin), cardiolipin, putrescine, cadaverine, or
hypochlorite compounds or metal ions (Fe2+, Zn2+, Cu2+). In
order to increase their effectiveness, there is a tendency to
develop formulations for oral hygiene which best use the
potential of the above-mentioned substances [6, 61, 62].
Biofilm structure
The formation of biofilm is a multistep and very complicated
process. A number of relevant factors and conditions are
required in the oral cavity for the process to run correctly.
Interactions occurring between agglutinins of saliva and
bacteria, and simultaneously between microorganisms, might
cause the formation of fur composed of cells beginning the
colonization: Actinomyces species, Streptococcus species,
Lactobacillus species, Candida species. They transform into
different types of biofilm in the first layer of subgingival
plaque. Biofilm maturation is followed by the aggregation of
subsequent bacteria and their growth. After 7 days, the
number of Streptococcus bacteria decreases, but the number
of Fusobacterium nucleatum increases. After 3 weeks, intact
subgingival plaque begins to resemble morphologically
supragingival plaque [32].
In the architecture of supragingival biofilm, four layers can
be distinguished. The first layer of biofilm consists of cells
displaying little fluorescence relative to cells in the top layer.
This indicates the presence of Actinomyces sp. In this layer,
physiologically inactive or dead cells can also be found. In the
intermediate layer, many spindle-shaped cells are found,
whose fluorescence indicates Fusobacterium nucleatum and
Tannerella sp., mostly T. forsythia . These bacteria can benefit
from the proximal location of dead cells (e.g., they acquire
sugar building their cell wall). The third layer of biofilm and
the intermediate layer mainly consist of a bacterial cluster
termed the Cytophaga–Flavobacterium–Bacteroides (CFB),
which consists mainly of Gram-negative bacteria Tannerella
sp., Prevotella sp., and Bacteroidetes sp.
Apart from this, long cigar-like Synergistetes bacteria from
the A group forming palisade-like stroma are also found in
this layer. These bacteria are in direct contact with the cells of
the host immune system resembling polynuclear leukocytes,
which, thereby, suggests their important role in the
interactions occurring between host and biofilm. Observations
of the top biofilm layer have shown that Spirochaetes bacteria
are the most abundant. Among them, bacterial aggregates
called rough and fine brushes are found [32].
More heterogeneous than subgingival biofilm is
supragingival biofilm. It consists of two layers: basal and
top, described in Table 1. All the above-mentioned factors
and conditions provide an adequate oral microbial habitat for
various kinds of microorganisms. The varied morphology of
biofilm expands and targets attacks on potential anticaries
compounds. At the same time, however, it is a complex
structure, the variability of whichmakes it difficult to determine
the destination points that underlie effective prevention related
to the treatment of periodontal disease.
Interbacterial interactions and the process of biofilm
formation
Interactions between microorganisms colonizing the oral
cavity are consecutive major factors affecting the
development of biofilm [25, 63, 64]. Interactions occurring
between microorganisms can result in both the acceleration
and inhibition of this process. Thus, the virulence of S. mutans
depends not only on the environmental conditions of the oral
cavity, but also on the composition of the bacterial flora.
The analysis of interactions between S. mutans (as one
of the etiological factors of dental caries) and the components
of physiological flora, e.g., S. oralis , S. sanguinis , or
Lactobacillus casei , was made possible by the use of dual
cultures [25]. In studies on this topic, single bacterial cultures
acting as the control group were compared to dual cultures.
The results of the experiments are summarized in Table 2.
The study of Zijnge at al. [32] suggests that S. mutans and
S. sanguinis are microorganisms which possess an inhibitory
Table 1 Composition of supragingival biofilm (the table was prepared
based on data published by Zijnge et al. [32])
Basal layer—attached to the surface
of teeth and consists of four types
of biofilm
The first type:
- rod-shaped cells of Actinomyces
located vertically towards the
surface of the teeth
The second type:
- Actinomyces sp.
- cocci chains, not identified as
Streptococcus , located vertically
towards the surface of the teeth
The third type:
- filamentous bacteria
- Streptococcus creating distinct
colonies around yeast cells
(Candida sp.)
The fourth type:
- mainly Streptococcus developing
in the vicinity of Lactobacillus
sp. located vertically to the
surface of the teeth
Top layer—covers all types of
biofilm-forming basal layer
- Streptococcus sp. in a form of
heterogeneous distributed cells,
or as a flat, thin layer on the top
- heterogeneous distributed bacteria
creating CFB cluster
- external layer: Lactobacillus sp.
surrounded with cells with
various morphology
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effect on biofilm formation ability. Thus, taking into account
this observation, researchers have decided to isolate and
analyze proteins produced by S. salivarius [63]. Based on
these studies, they found that substances responsible for
biofilm formation inhibition are: fructosyltransferase (Ftf)
and exo-β-D-fructosidase (FruA).
Ftf is an enzyme involved in the metabolism of sucrose to
fructose characterized as an extracellular homopolymer, levan
(fructan). Next, the enzyme FruA performs a hydrolysis
reaction of the formed fructan to fructose. Fructosidase is
encoded by the FruA gene, which is identified in many
different species of streptococci and in fungi. The mechanism
of action of both enzymes allows them to effectively inhibit
the sucrose-dependent adhesion of the S. mutans pathway
[63]. Authors have confirmed the inhibitory effect of FruA
on the process of biofilm formation by S. mutans . To confirm
this, a fructanase mixture (the mixture used was derived from
a culture of Aspergillus niger and showed significant FruA
activity) containing exo- and endo-inulinase was added
for the cultivation of this bacterium. It was shown that
these enzymes did not affect bacterial growth inhibition;
however, they strongly inhibited their ability to form
biofilm [63]. In addition, the ability of FruA fructosidase
to use sucrose from the oral environment causes a lack of
availability of this carbohydrate for S. mutans . This phenomenon
is observed because FruA digests sucrose before S. mutans
glucosyltransferases manage to produce the glucans necessary
for biofilm formation [63].
Another microorganism strongly affecting S. mutans -
induced biofilm in the oral cavity is Lactobacillus spp. (LB).
LB bacteria are commensal microorganisms colonizing,
among others, the human oral cavity. LB is strongly associated
with the development of dental caries in the dentine, because it
ferments sugars into acidic products, which decrease the pH in
the oral cavity, and promote the development of biofilm
(Fig. 3) [65]. On the other hand, low pH and antibacterial
agents, such as hydrogen peroxide or bacteriocins produced
by LB microorganisms, favor the purification of the oral
cavity from microorganisms which are non-adaptive to such
environmental conditions, for instance, Porphyromonas
gingivalis [65]. Thanks to such properties, LB bacteria can
be widely used as probiotics [34, 65–68]. LBmicroorganisms,
by interacting with other microorganisms and the production
of antimicrobial proteins, contribute to maintaining the
balance in the natural flora of many ecosystems, e.g., the oral
cavity [66].
Research conducted on various Lactobacil lus
microorganisms has confirmed the inhibitory effect of many
of them on cariogenic microorganisms colonizing the oral
cavity, among others S. mutans . Among the most active
microorganisms are: L. paracasei , L. plantarum , L.
salivarius , and L. rhamnosus [66]. It is also known that the
above-mentioned probiotics do not affect the adhesive ability
of S. mutans ; however, they are able to inhibit the proliferation
of the pathogen, and, thus, retard biofilm formation and
development [68, 69]. Unfortunately, the mechanism of
interaction between Lactobacillus and S. mutans has not yet
been sufficiently investigated. Detailed in vitro studies
focused on Lactobacillus reuteri [34, 65] have shown that
different strains of this species interact with S. mutans with
different forces. These interactions are dependent on the pH of
the environment and the ability of probiotics to produce
hydrogen peroxide and reuterin, an antibacterial protein
formed from glycerol, resistant to proteolytic and lipolytic
enzymes [24, 68]. The strains also differed in terms of their
ability to adhere to surfaces coated with saliva. This feature is
very important because bacteria unconjugated to the solid
phase are quickly removed by swallowing [63]. Similar
differences in activity against S. mutans have been observed
among different strains of Lactobacillus salivarius [66].
The role of Lactobacillus bacteria to sustain oral purity is
also a result of their specific coaggregation with S. mutans
cells. This relationship applies to L. paracasei and L.
rhamnosus [67]. The fusion of microorganisms in common
aggregates prevents the adhesion of S. mutans to the surface
of teeth and gums. This allows the removal of the pathogen
from the oral cavity with saliva before the first stage of biofilm
formation begins, that is, adhesion [67].
Tahmourespour et al. showed that a biosurfactant
derivative produced by probiotic bacterium, Lactobacillus
fermentum , inhibits biofilm formation. In the presence of S.
mutans , the above-mentioned ability to form a derivative was
inhibited, probably due to the inhibition of two key enzymes,
GtfB and GtfC. A decrease in the gene expression encoding
Table 2 The results obtained in a study with the use of dual cultures (the table was prepared on the basis of data published by Wen et al. [25])
Dual culture Biofilm formation Expression of pathogenic factors of S. mutans
spaP gtfB gbpB luxS
S. mutans + S. oralis Not a relevant change 30-fold decrease No decrease 30-fold decrease 15-fold decrease
S. mutans + S. sanguinis Significantly important decrease Small decrease Small decrease Small decrease Change not statistically significant
S. mutans + L. casei Small increase(around 2-fold) 40-fold decrease 40-fold decrease 40-fold decrease 7-fold decrease
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the mentioned glucosyltransferases in the presence of a
biosurfactant derivative produced by L. fermentum [70, 71]
has been reported. Ogawa et al. noted that S. salivarius
can inhibit biofilm formation. Exo-beta-D-fructosidase
synthesized by S. salivarius blocks the synthesis of
polysaccharides, which reduces the amount of extracellular
matrix produced by S. mutans [63].
Interactions occurring between S. mutans and other
microorganisms in the oral cavity may contribute to both the
development as well as the inhibition of biofilm formation.
Through ongoing research, we have obtained new data on
these interactions which enables the search for and use of
novel, more specific and effective measures for the prevention
of and fight against dental caries. In this fight, it is important to
utilize, apart from synthetic products, the potential of natural
products, such as probiotics and specific antimicrobial
proteins. These substances exhibit a significantly lower
number of side effects than artificially made specimens and
are suitable for use under specific environmental conditions,
which allows a high level of activity of the specimens to be
maintained over a long period of time.
Inhibition of biofilm formation—treatment perspectives
in dental caries
First, second, and third-generation medicines (phenolic
compounds, chlorhexidine, delmopinol)
The growing problem of strain resistance to antibiotics
compels us to seek other methods which deal with pathogens
that occur in the oral cavity. Nowadays, we know of a number
of substances with effective antimicrobial activity inhibiting
biofilm development, for instance, chlorhexidine [72],
delmopinol [73], or phenolic compounds [74]. Unfortunately,
most of these substances cause side effects such as vomiting,
diarrhea, addiction, or teeth discoloration. Therefore,
alternative substances of antibacterial activity are being sought
which would be safe for the users [33, 75].
“Liquid enamel”—calcium phosphate
For many years, the primary role in the fight against dental
caries has been played by calcium phosphate, which possesses
remineralization properties [76–78]. A special calcium
phosphate resin, which was designed for the gradual release
of large amounts of these elements in places that require
reconstruction, was established very quickly. Later, this
compound gained the form of a nanoparticle of amorphous
calcium phosphate composite (NACP), which was also as
widely used in dentistry as its precursor. The advantages of
the nanocomposite are:
– Improved mechanical features for its use in dentistry as
compared to the classic combination of elements;
– Increased release of ions in acidic environments favoring
the formation of voids and dental caries;
– Fast neutralization and raising of low pH to a safe level
(about 6).
[76, 77].
Nanoparticles of quaternary ammonium salts (QAS)
In the search for a substance which, apart from remineralization
properties, would possess antibacterial ability, NACP was
enriched with quaternary ammonium salts (QAS). A specific
application was found for a quaternary ammonium called
dimethacrylate (QADM). This compound has two active
antibacterial domains at its ends, which increase the desired
properties, and, additionally, mixes with other dental media
easily [77]. Thanks to this change, a new composite of strong
antibacterial activity was found. Its application results in
shortening microorganism viability both as a planktonic form
and in biofilms among others (Streptococcus sp. and
Lactobacillus sp.), decreasing acid production by bacteria and
a reduction of microorganism metabolic activity [76, 77]. This
is possible thanks to the amphiphilicity of QAS compounds,
which allow for these substances to react with the lipid part of
the cell membrane and interfere with its function. As a result, it
indirectly affects the activity of enzymes involved in the
transport of substances through the membrane lipid, and, thus,
alters the metabolic activity of bacterial cells [79].
Antibacterial nanoemulsions
Lethal QAS properties against a broad spectrum of
microorganisms have also been used in antibacterial
nanoemulsions. In this context, cetylpyridinium chloride (CPC)
was used [80]. Antibacterial nanoemulsion is characterized as
a dispersing substance, namely, water and a lipid substance
composed of surfactant, which forms nanoemulsion droplets.
It is not toxic to humans or animals; however, it exhibits
antibacterial, antifungal, and antiviral activity. Antibacterial
properties of the emulsion result from the activity of
nanodrops on bacterial cell membranes destabilizing the
integration of its lipids [80].
Cetylpyridinium chloride (CPC)
CPChas the ability to inhibit Ftfs enzymes (fructosyltransferases),
which play an important role in microorganism-induced
biofilm formation in the oral cavity. Thanks to this property,
CPC plays the role of an antibacterial substance (affecting the
cell membrane of a microorganism) and a substance inhibiting
the development of biofilm. Increasing the efficiency of
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nanoemulsions through CPC enrichment has led to their wider
application in products for oral hygiene, such as toothpastes
and mouthwashes, and in dental materials, e.g., varnishes and
dental fillings [80].
12-methacryloyloxydodecylpyridinium bromide (MDPB)
Among QAS, 12-methacryloyloxydodecylpyridinium
bromide (MDPB) has also found an application in the fight
against dental caries [81, 82]. The properties ofMDPB and the
possibility of its application have attracted the attention of
research groups [82]. In experiments, the authors have
investigated the effect of MDPB on the bacterial flora of the
oral cavity, interactions with dental materials, and the
possibility of a synergistic effect of this compound with
nanoparticles of silver (NAg).
MDPB is a monomer characterized by antibacterial
activity against aerobic and anaerobic bacteria isolated
from translucent zones (i.e., Actinomyces , S. mutans ) and
antifungal activity (e.g., Candida albicans ) [82]. Stiffened
by polymerization of the filling bonding layer, it remains
active against pathogens and, at the same time, does not
negatively affect either human cells or the binding capacity
of the filling material [82].
Silver nanoparticles
Silver compounds became the research objective for Cheng
et al. [81], who drew attention to their application in
conjunction with QADM. Silver is known for its lethal
activity against a wide spectrum of bacteria, viruses, and
fungi. Its antibacterial activity is due to the ability of cell
membrane disintegration, internal penetration, and destruction
of intracellular organelles. An additional mechanism allowing
for the inactivation of bacterial enzymes by inhibiting
bacterial DNA replication capability enhances the efficacy of
silver compounds. Low toxicity and long-term antibacterial
activity due to the gradual release and lower resistance of
bacteria against these compounds in relation to antibiotics
are other advantages in the fight against microorganisms
[81–83]. The sheer number of mechanisms and properties
describing the activity of substances containing silver particles
lead to the inability for microorganisms to sustain full
protection against their effects. An additional difficulty is the
role of silver compounds as catalysts, rather than substances
participating in chemical reactions [84].
Silver nanoparticles have a huge active surface, and,
therefore, their level in dental composites is estimated at only
0.05 to 0.1 % by weight. This proportion provides both
effective antibacterial activity as well as a lack of effect on
the mechanical filling properties [81].
NAg with MDPB and NAg with QADM
Research conducted by both groups showed that the
combinations of NAg with MDPB and NAg with QADM
givemuch better results than the use of these substances alone.
Based on Table 3, it can be observed that the combination of
silver nanoparticles with MDPB and QADM does not affect
the mechanical properties of the dental material and is not
toxic to human cells. A major advantage of such combinations
is the increase in the ability to inhibit microorganism growth,
as well as the significant reduction in their metabolic activity
and vitality.
Variations of silver nanoparticles with MDPB, QADM,
and with silver diamine fluoride (SDF)
The combination of silver with fluoride led to the formation of
silver diamine fluoride (SDF), characterized by antibacterial
properties, for which the metal component is responsible, and
remineralization properties due to the presence of fluoride
Table 3 The effect ofMDPB +NAg andQADM+NAg on chosen traits (the table was prepared based on data published byCheng et al. [81] and Zhang
et al. [82])
Trait Control MDPB + NAg QADM + NAg
Growth inhibition zone 1 mm 10-fold higher 8-fold higher
The strength of binding of dental material 30–32 MPa No changes No changes
Metabolic activity of bacteria measured by absorbance
in the enzymatic assay (reduction of MTTa at
540 nm wavelength).
0.5 A540/cm
2 0.05 A540/cm
2 No changes
Viability of bacteria described as a ratio of the number
of live cells to dead cells based on the image from
a fluorescence microscope
Long lifetime Significantly lowered in
comparison to control
Significantly lowered in
comparison to control
CFU (colony forming unit, number of microorganisms
in the study material) after application of
antibacterial agents
23 × 106 for control MDPB
2.5×106 for control QADM
0.5×106 0.9×104
aMTT – tetrazolium dye
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[85]. It has been shown that SDF can be used as an element of
dental caries prevention [86], as well as a substance inhibiting
the development of disease by reducing the amount of
cariogenic microorganisms in the oral cavity and that it has a
positive influence in zones of tooth enamel demineralization
[85]. During studies on the described compound, the
sensitivity of S. mutans and Actinomyces naeslundii to its
function was also demonstrated [87].
However, studies examining the effects of SDF on dual-
species biofilm formed by S. mutans and Lactobacillus
acidophilus illustrate much better the effectiveness of this
compound in the natural oral environment, in which biofilm
is characterized as a structure of multi- and not single species.
Mei et al. [72] showed that, in dual-species biofilm, the
antibacterial activity of silver ions is much lower than in the
biofilm of single species; however, it does not disappear
completely. This is confirmed by the ratio of dead and live
cells, which, for the control, was equal to 0.02, whereas for the
samples with SDF addition, it was 6.74. These studies, apart
from confirming SDF antibacterial activity against S. mutans
and L. acidophilus , also proved that this substance slows the
process of enamel demineralization and protects collagen
from damage. This dual action of SDF may contribute to a
wider use in oral hygiene products and to clinical success in
the fight against dental caries.
Natural inhibitors: chitosan
Antibacterial substances which could be included in the
formulations of oral hygiene products and would not exert
side effects are still being researched. One such substance is
chitosan, a polysaccharide formed by the N-acetylation
reaction of chitin [88]. Both compounds are present in the
plant, fungi, and animal worlds, and have natural antibacterial
and antifungal properties. A limitation in the use of chitosan
for oral hygiene products, however, was proven by its
insolubility in water, because the compound is dissolved only
in acids. Attempts have been made to modify this property,
and as a result of the Maillard reaction or sugar modification,
water-soluble chitosan of unchanged antibacterial properties
was obtained. It has been shown [88] that such modified
chitosan exhibits the highest antibacterial activity against
microorganisms isolated from the oral cavity in an environment
with a pH range between 5 (for Klebsiella pneumoniae ,
Streptococcus mutans , Staphylococcus aureus) and 8 (for
Enterobacter gergoviae , Lactobacillus brevis , Staphylococcus
saprophyticus).
The optimum temperature for chitosan activity, in which
the antibacterial activity remained at the level of 50–96%,was
estimated at 37 °C in relation to the above-mentioned bacterial
species. For K. pneumoniae , L. brevis , and S. saprophyticus ,
the minimum bactericidal concentration of chitosan (MBC)
was 500 μg/ml, whereas for other species, it was 400 μg/ml. It
was also shown that 5 s is sufficient for chitosan to exhibit
antibacterial activity in relation to the above-mentioned
microorganisms species at the level of 99.6 %, and 20s was
required to reach the level of 99.9 %.
Thus, it was proven that water-soluble chitosan has a
comparable efficacy in the fight against dental caries in
relation to commonly used antibacterial mouthwashes for oral
hygiene. A very strong argument for the use of chitosan in
such formulations is also its much lower toxicity than the
conventionally used alcohols, chlorhexidines, or cetylpyridinium
chloride [88], which are commonly used in products for oral
cavity disinfection in diseases of the upper respiratory tract,
e.g., Tantum Verde.
Natural inhibitors—antimicrobial peptides (AMPs):
chrisofsin-1, D-Nal-Pac-525
Another safe and potential solution to the problem of dental
caries in humans are antimicrobial peptides (AMPs). They
exhibit a lethal effect against many microorganisms but do
not cause side effects for humans [33].
AMPs represent a family of short polypeptides, typically
associated with congenital human and other organism immune
systems. An example of such a protein is chrisofsin-1
amphipathic, an α-helical protein of broad activity spectrum
against both Gram-negative and Gram-positive bacteria.
Chrisofsin-1 possesses a hydrophilic domain at the C-terminal
end of the polypeptide chain.
Via electrostatic interactions with negatively-charged
phospholipids of bacterial cell membranes, it covers the
membrane tightly, and then the hydrophilic domain penetrates
into the structure of the membrane, forming a number of pores
inside. Wang et al. observed the first changes in cell shape
during their studies [33] using chrisofsin-1 at concentrations
of 2–4 mg/ml (depending on the bacteria species). Thus,
chrisofsin-1 exhibits potent destructive action against lipid
components of microorganism cell membranes, such as S.
mutans , S. sanguinis , S. sobrinus , S. gordonii , Actinomyces
sp., and Lactobacillus sp. and, thus, it is able to induce
disintegration and bacterial lysis.
This contributes to reduced viability of pathogens, both as
planktonic forms as well as those grouped in biofilm.
Compared to S. mutans , chrisofsin-1 exhibits lethal activity
after 30 min with the use of an 8 times higher concentration
than the minimum inhibitory concentration (MIC). For
comparison, E. faecalis was destroyed after 5 min and L.
fermentis after 60 min with the use of 12 times the MIC.
Among the strains under investigation, only A. viscosus was
observed to be more resistant than S. mutans . Its eradication
required the application of 8 times the MIC for 60 min. This
shows the different effects of chrisofsin-1 in relation to
particular bacterial species [32].
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Microorganisms remaining in the biofilm structure are 10–
1,000 times more resistant than those in the planktonic phase.
For this reason, AMPs could be used most effectively in the
early stages of biofilm formation. It would prevent its growth
and the colonization of the oral cavity by other pathogens. In
the phase of biofilm maturation, AMPs would only delay the
cariogenic process [33].
The D-Nal-Pac-525 peptide appeared to be another
example of an AMP with high antibacterial activity. The high
anticaries activity of D-Nal-Pac-525 peptide is associated with
the tryptophan conversion in the tryptophan-rich (Trp-rich)
Pac-525 peptide fragment to the D-β-naphthylalanines
fragment [62]. Studies with the use of scanning and
transmission electron microscopes have shown that the D-
Nal-Pac-525 peptide causes morphological changes and cell
membrane damages of S. mutans with a MIC of 4 ug/ml,
while the inhibition of biofilm formation was observed under
anMIC of 2 ug/ml. The effective anti-biofilm protection of the
D-Nal-Pac-525 peptide was highlighted in the first stage of its
formation (planktonic and colonization phase of bacteria)
(Fig. 2), with no effect on pre-existing bacterial biofilms.
The above-mentioned results are comparable to beta-
defensin (6 mM) action in human saliva. Data suggest the
use of AMPs exemplified by D-Nal-Pac-525 as new
therapeutic agents which combat the problems caused by the
occurrence of bacterial strains resistant to antibiotics [62].
The problem of infectious diseases is inherently associated
with the growing number of microorganisms becoming
resistant to a broader spectrum of antibiotics (multidrug
resistance). Therefore, the attention of scientists has
increasingly been drawn to antibacterial, antifungal, and
antiviral substances of natural origin. Many metabolites of
plant origin, such as polyphenols, alkaloids, tannin,
terpenoids, steroids, or flavonoids, are known for such
properties [61, 89, 90]. Because of their proven antibacterial
activity, these compounds act as supplements in oral hygiene
products.
Most of the above-mentioned substances have found
an application in dentistry. They are included in
composites and dental restorative resins, the properties
of which allow for the reduction of biofilm formation
and reduce the probability of dental caries episodes at
the same place. They have been introduced into treatment
because commonly used methods of treating developing
dental caries usually do not allow for the removal of bacteria
from the mineralized tooth tissues. In such situations, it is
suggested that antibacterial agents should be applied on
already developed dentin [91]. These are usually fillings
which release ions [92] in the form of dicalcium phosphate
anhydrous nanoparticles (DPCA) or tetracalcium phosphate
(TTCP) often enriched with fluorine [92], or modifications of
such fillings, e.g., with the addition of QAS or silver
nanoparticles [76, 77, 81, 82].
Iodine compounds
Studies on substances allowing for the reduction of dental
caries incidence also include iodine compounds such as
potassium iodide or povidone–iodine (PVP-I). PVP-I is a
complex of iodide and polyvinylpyrrolidone, which is a
specific “reservoir” of free iodine ions forming an active
domain of the whole structure. Iodine slowly released from
the complex is able to penetrate the bacterial membrane and
enter into the cytosol, where it deactivates the key proteins,
fatty acids, and nucleotides in the metabolism of the cell [93].
Additionally, the slow release of iodine reduces its toxic
effects for human cells [94] and its short-term use does
not irritate even damaged oral mucosa. No side effects,
such as discoloration of teeth, tongue, or taste change, have
been reported [95].
Hosaka et al. [95] decided to test the antibacterial activity
of PVP-I in relation to the two microorganisms associated
with oral cavity diseases, Porphyromonas gingivalis and
Fusobacterium nucleatum . They showed that PVP-I, at a
concentration of 7 %, is able to reach the activity allowing
100 % of P. gingivalis species to die after 3 min, and an
identical effectiveness against F. nucleatum with the use of
5 % of PVP-I was observed after 30 s. The results obtained for
dual-species biofilm formed by the microorganisms under
investigation indicated that this biofilm is 200 times more
resistant to the activity of the tested substance than mono-
species cultures, although the activity of 5 % PVP-I allows
bacteria which form this biofilm to be killed.
Unfortunately, it has also been shown that the concentrations
of PVP-I (0.23–0.47 %) used in common mouthwashes are not
sufficient for a significant reduction of P. gingivalis and F.
nucleatum biofilm formation ability during a time of 30 s to
1 min, which was estimated as the average time of
mouthwashing by the public [95]. Based on these reports, one
may conclude that other bacterial species will also exhibit a
different sensitivity to PVP-I activity, and a multi-species
biofilm will be much more resistant to both planktonic cells as
well as structures formed by a lower number ofmicroorganisms.
The antibacterial activity of PVP-I has also been tested for
S. mutans strains isolated from children with early childhood
caries [96, 97]. It has been proven that the application of 10 %
PVP-I on healthy teeth and on teeth with dental caries every
3 months for 1 year significantly reduces the number of these
microorganisms in the oral cavity as compared to baseline
levels [96, 98]. This reduced number of cariogenic bacteria is,
therefore, likely to reduce the probability of childhood dental
caries. Similar conclusions can be drawn from studies
conducted on a group of 172 children, which showed that
combination therapy of dental caries through the application
of 10 % PVP-I and dental varnish containing 5 % sodium
fluoride reduces the incidence of new carious lesions by 31 %
in relation to the application of the varnish alone [86].
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Ursolic acid
Composite resins containing ursolic acid which inhibited the
biofilm formation of S. mutans at a concentration of 0.1–
0.5 wt.% [99] have been proposed as another solution to the
problem of dental caries. This compound has similar
properties to those tested in clinical trials: triterpenoids of
recorded anticancer, antiwrinkle, and antibacterial activity.
Aromatic amino acid pathways
There is little information concerning the effect of amino acids
on the ability of S. mutans to form biofilms. Kolodkin-Gal
et al. conducted a study on biofilm structure decomposition on
the example of Bacillus subtilis . This microorganism
produced a factor which inhibited biofilm formation and next
induced structure disassembly. Analysis of this factor’s
composition demonstrated that it is a mixture of four D-
amino acids: leucine, methionine, tyrosine, and tryptophan
[100]. A similar inhibitory effect of the D-amino acid
mixture was observed in the case of biofilm formation by
Staphylococcus aureus [101] and Pseudomonas aeruginosa
[102]. Recent studies have indicated that increased levels of L-
tryptophan itself may also give the signal for biofilm
decomposition; a suitable experiment was conducted on the
example of biofilm formed by E. coli [103]. Our study
indicates that another aromatic L-amino acid, i.e., tyrosine,
has similar properties and may inhibit biofilm formation by
S. mutans (paper submitted to the editorial board). It needs to
be verified as to whether other aromatic amino acids may
exhibit anti-biofilm formation activity for S. mutans species,
and also whether inhibition caused by these compounds is
limited to ex vivo models, as well as whether and to what
degree they may be applied in clinical situations (proposed
animal model).
The increasingly broader range of substances protecting us
from the occurrence of carious lesions while not causing side
effects creates hope for the design of oral hygiene products
allowing for the effective fight against this disease and for the
complete protection of children from the development of early
caries lesions in primary teeth.
Summary
Studies on biofilm formed by S. mutans clearly show that
the virulence of S. mutans strains is dependent on
environmental conditions, and, thus, on in vivo model
host-dependent characteristics. On the other hand, to form
a biofilm structure, it is not sufficient to ensure appropriate
environmental conditions. Microorganisms alone must possess
characteristics which, in terms of the above-mentioned
favorable conditions, will allow the adhesion and formation
of microcolonies [6, 35, 36].
Cariogenic strains of S. mutans exhibit large variation due
to the occupation and expression of characteristics considered
as virulence determinants: (A) most S. mutans strains exhibit
the ability to survive and reproduce in acidic pH, without
eliminating the possibility to survive in alkaline medium
levels (described in case studies isolated cases of bacteremia),
(B) most S. mutans strains possess the activity of specific
proteins (enzymes) associated with biofilm formation,
depending on a number of biochemical properties of the host
(EPS production, the condition of the host immune system).
Biofilm formation in the oral cavity is a complex process,
dependent not only on EPS produced by S. mutans and the
host, but also on other species colonizing the oral cavity. The
occurrence of potentially non-pathogenic species in the oral
cavity environment seems to be the key point.
This study is an introduction to the research which aims to
confirm or exclude the virulence of selected Streptococcus
strains in clinical material, as well as shedding new light on
the development of potential compounds blocking the
metabolism of Streptococcus mutans through influence on
specific proteins involved in the formation of the complex
structure which is a biofilm.
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